| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CANN sits in the Pharmaceuticals industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 11, 2016 | Feinsod Michael | Director | Buy | 3,000 | $0.41 | $1,222.50 | +23.6% | |
| Jan 20, 2016 | Frichtel Robert Lawrence | CEO | Buy | 2,000 | $0.48 | $950.00 | - | |
| Dec 15, 2015 | Feinsod Michael | Director | Buy | 12,700 | $0.45 | $5,753.55 | +37.7% |